CADENCE CAPITAL MANAGEMENT LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
CADENCE CAPITAL MANAGEMENT LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$1,087,000
-17.1%
33,605
+4.5%
0.16%
-28.8%
Q1 2020$1,311,000
-38.1%
32,168
-6.3%
0.22%
-2.6%
Q4 2019$2,118,000
-27.3%
34,348
-14.1%
0.23%
-44.9%
Q3 2019$2,915,000
-12.0%
40,003
-0.7%
0.41%
+25.1%
Q2 2019$3,311,000
-22.6%
40,284
-33.6%
0.33%
-14.0%
Q1 2019$4,277,000
+58.2%
60,630
+1.0%
0.38%
+41.0%
Q4 2018$2,703,000
-13.7%
60,047
+8.4%
0.27%
+61.5%
Q3 2018$3,131,000
+1.7%
55,384
+20.1%
0.17%
-7.1%
Q2 2018$3,080,000
+110.2%
46,108
+83.3%
0.18%
+91.6%
Q1 2018$1,465,000
-6.6%
25,161
+3.4%
0.10%
-5.0%
Q4 2017$1,568,000
-10.6%
24,326
-27.2%
0.10%
-9.1%
Q3 2017$1,753,000
+486.3%
33,402
+422.2%
0.11%
+423.8%
Q2 2017$299,000
-0.3%
6,397
+5.7%
0.02%0.0%
Q1 2017$300,000
-41.7%
6,052
-28.7%
0.02%
-41.7%
Q4 2016$515,000
-53.9%
8,492
-49.5%
0.04%
-56.1%
Q3 2016$1,117,000
+18.1%
16,829
-0.7%
0.08%
+15.5%
Q2 2016$946,000
+71.4%
16,941
+3.4%
0.07%
+82.1%
Q1 2016$552,000
+66.8%
16,387
+123.7%
0.04%
+77.3%
Q4 2015$331,000
+7.1%
7,327
-6.4%
0.02%0.0%
Q3 2015$309,000
-51.0%
7,824
-23.0%
0.02%
-37.1%
Q2 2015$631,000
-39.3%
10,164
-38.8%
0.04%
-45.3%
Q1 2015$1,040,00016,6200.06%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 327,929$9,218,0003.24%
Parkman Healthcare Partners LLC 107,911$3,033,0000.89%
Global Alpha Capital Management Ltd. 350,231$9,845,0000.85%
MARATHON CAPITAL MANAGEMENT 75,010$2,109,0000.60%
TANG CAPITAL MANAGEMENT LLC 100,000$2,811,0000.56%
EMERALD ADVISERS, LLC 354,045$9,952,0000.38%
Sio Capital Management, LLC 40,000$1,124,0000.37%
EMERALD MUTUAL FUND ADVISERS TRUST 299,493$8,419,0000.37%
Stonepine Capital Management, LLC 26,060$733,0000.30%
Mitsubishi UFJ Asset Management (UK) Ltd. 23,000$646,530,0000.29%
View complete list of ANI PHARMACEUTICALS INC shareholders